Mr. Brady Cobb reports
SOL GLOBAL SIGNS BINDING AGREEMENT WITH MERIDA CAPITAL PARTNERS' SUBSIDIARY TO ACQUIRE MICHIGAN FULLY LICENSED CANNABIS BUSINESS
SOL Global Investments Corp. has entered into a binding letter of intent (LOI) with cannabis-focused private equity firm Merida Capital Partners dated April 23, 2019, to acquire Merida's Michigan subsidiary, MCP Wellness Inc., for an aggregate purchase price of $150-million (U.S.). MCP Wellness, a special-purpose vehicle (SPV) created to invest in Michigan cannabis operations, currently holds the rights to acquire two Michigan cultivation licenses, a processing license, and 3 fully licensed cannabis provisioning centers in Michigan with a fourth provisioning center scheduled to open in Ann Arbor in May.
MCP Wellness also has plans to open an additional nine municipally-approved provisioning centers by August 2019. Assuming MCP Wellness' expansion plans are completed as scheduled, SOL Global and Merida expect Michigan gross revenue from the acquired business to generate in excess of US$61 million in calendar year 2019 and more than US$121 million in 2020. Below is a summarized table of projected total revenue, costs of goods sold, gross profit, expenses and net income before tax for the 2019 and 2020 fiscal years.
Projected Income Statement
Expressed in Thousands (000) and in United States Dollars
Total Revenue $ 61,808$121,160
Cost of Goods Sold $ 32,893$ 57,512
Gross Profit $ 28,914$ 63,648
Gross Profit %age 48% 48%
Total Expenses $ 10,984$ 20,310
Net Profit, before Tax $ 17,930$ 43,338
Gross Profit %age 29% 36%
The Acquisition, which is subject to the negotiation and execution of a definitive purchase agreement and regulatory approval for the transfer of licenses within Michigan, is expected to close in May 2019 and will not dilute SOL Global's shareholders.
SOL Global owns 3 Boys through its wholly-owned subsidiary, CannCure Investments Inc. ("CannCure"). Following the closing of the Acquisition, SOL Global intends to combine the acquired Michigan business into CannCure to form a new multi-state operator (the "MSO"). Under the terms of the LOI, the purchase price will be satisfied by way of US$35 million in cash and US$115 million in equity consideration in CannCure, resulting in Merida owning approximately 42% of CannCure (including after giving effect to the proposed CannCure private placement financing described below). In regard to the cash consideration, US$9 million will be sourced from cash on hand and US$24 million will come from a private placement financing of CannCure equity and/or debt on pricing and terms to be determined by management following market assessment. In addition to the Acquisition, the retrofitting of an approximately 110,000 square-foot cultivation facility in Michigan will begin immediately to service the growing retail footprint and demand within Michigan with high-quality flower and award-winning cannabis strains from 3 Boys' respected growers. 3 Boys will continue to strengthen its operations in Florida; as announced on April 22, 2019, 3 Boys has already received approval from the Florida Department of Health, Office of Medical Marijuana Use ("OMMU") to begin processing and dispensing cannabis flower and pre-rolled products at its new, state-of-the-art extraction and processing facility in Indiantown, Florida. 3 Boys expects to open its first two (2) retail dispensaries in Florida before the end of the second quarter, and an additional 12 such locations by March 31, 2020. According to Marijuana Business Daily, the number of qualified active cannabis patients in Florida nearly tripled in the twelve months between December 2017 and December 2018, from 56,537 to 159,107. As of April 19, 2019, there are currently 272,366 qualified patients in Florida, according to the latest weekly update from the OMMU. 3 Boys expects this explosive rate of growth in the Florida market to continue.
Merida, which recently launched its third fund, will contribute both operational talent and oversight into the combined entity. As part of the Acquisition, certain key executives of the Michigan operation will join the MSO and serve on the leadership team with an emphasis on retail operations.
"MCP Wellness's acquisition of the Michigan licenses, once completed, will be the perfect complement to 3 Boys' operations in Florida, as both states offer tremendous growth potential and this partnership will combine talent, industry leading genetics and processing, plus cultivation and retail expertise across two of the most coveted and revenue generating markets in the U.S." said Brady Cobb, CEO of SOL Global. "This acquisition will help ensure that SOL Global, through the MSO, will be able to execute on its visionary vertically integrated cultivation and retail strategies in the United States' most promising cannabis markets."
"Over the past several years, Michigan has become one of the country's largest medical cannabis markets, projected at nearly US$900 million for 2019, according to New Frontier Data," said Mitch Baruchowitz, managing partner of Merida Capital Partners. "With adult use coming in 2020, Merida is excited by the opportunity to combine one of Michigan's leading retail operations with a Florida operator while aggressively pursuing additional acquisition targets across several states that will help create a more diversified company."
SOL Global and Merida Capital are also in active negotiations on acquisitions for the MSO in additional states. Specifically, SOL Global is finalizing negotiations to acquire an industry leading California cultivator and processor with superior genetics and a chain of prime retail dispensaries in California, and at the conclusion of that transaction, SOL Global intends to pursue a "going public transaction" of the MSO by way of an initial public offering, reverse takeover, plan of arrangement or other similar transaction that will result in the listing of the shares of the MSO on a recognized Canadian stock exchange. SOL Global and Merida both intend to be significant shareholders of the MSO following the going public transaction.
About SOL Global Investments Corp.
SOL Global is an international investment company with a focus on, but not limited to, cannabis and cannabis related companies in legal U.S. states, the hemp and CBD marketplaces and the emerging European cannabis and hemp marketplaces. Its strategic investments and partnerships across cultivation, distribution and retail complement the company's R&D program with the University of Miami. It is this comprehensive approach that is positioning SOL Global as a future frontrunner in the United States' medical cannabis industry.
We seek Safe Harbor.
© 2020 Canjex Publishing Ltd. All rights reserved.